Should We Use N-Acetyltransferase Type 2 Genotyping To Personalize Isoniazid Doses?
Kinzig-Schippers, M., Tomalik-Scharte, D., Jetter, A., Scheidel, B., Jakob, V., Rodamer, M., Cascorbi, I., Doroshyenko, O., Sorgel, F., Fuhr, U.Volume:
49
Language:
english
Journal:
Antimicrobial Agents and Chemotherapy
DOI:
10.1128/AAC.49.5.1733-1738.2005
Date:
May, 2005
File:
PDF, 111 KB
english, 2005